REPORT HIGHLIGHTS

• Despite the complaints of health care being too expensive, the U.S. pharmaceutical industry is expected to offer increasing opportunities for advanced drug delivery systems, with the U.S. market for the systems estimated at $16.3 billion in 2000. The efficacy, safety, and convenience of the technologies should maintain average annual growth of 10.9% over the next five years, when sales are predicted to be about $27.4 billion.
• At $13.8 billion in estimated 2000 manufacturers' sales, standard controlled release technologies (microencapsulation, polymer/membrane, and coatings) dominate the market for advanced drug delivery systems. The intense competition in generic products is stimulating growth (7.2%), especially in oral formats, both osmotic and microencapsulated. Demand for injected sustained release products is also spurring growth. The widespread interest in controlled released systems should result in sales reaching $19.6 billion in five years.

REPORT SCOPE

INTRODUCTION

REASON FOR DOING THE STUDY

The U.S. pharmaceuticals industry offers increasing opportunities for advanced drug delivery systems to encroach upon and gain a competitive edge over their conventional counterparts. This updated Communications Co. (BCC) report, Advanced Drug Delivery Systems, explores some of those opportunities.

STUDY GOAL AND OBJECTIVES

The goal of BCC's Advanced Drug Delivery Systems report is to provide an in-depth analysis of the U.S. market for alternative means of delivering drugs. Objectives for this technical/marketing report include the following: 1) to track significant advances with current market applicability; 2) to discuss novel technologies with near-term market impact; 3) to delve into emerging techniques with possible future viability; and 4) to provide the data necessary to evaluate U.S. market trends and economic indicators regarding this industry.

THE CONTRIBUTION OF THIS STUDY AND FOR WHOM

As a valuable basic market reference and technology summary, this BCC study should contribute to a better understanding of the market dynamics for advanced drug delivery systems. Senior and marketing personnel, corporate and product planners, investment analysts, investors, and venture capitalists can use this report to track potential competition and to identify market opportunities within the U.S. pharmaceutical industry.

SCOPE AND FORMAT

The scope of Advanced Drug Delivery Systems includes discussions of major techniques now in use, products that incorporate these techniques, technologies under development, their impact on present drug sales, and major players in the industry. The report organizes information from diverse sources into a cohesive unit that includes an overview section, a structure of the industry section, and three technology review sections. The technology sections focus on controlled release, site-selective, and transmucosal systems, quantify their U.S. market values, and make market projections for a five-year time period (2000-2005).

METHODOLOGY AND INFORMATION SOURCES

The methodology employed and information sources used to obtain the data found in Advanced Drug Delivery Systems include extensive telephone interviews with key executives from the leading U.S. pharmaceutical and drug delivery systems market participants, drug reformulators, academic researchers, and pharmaceutical industry observers. The expert and reasoned comments of these sources, combined with information gathered from available trade journals, online data searches, and evaluations of company reports, press releases, and patents, provide the basis for the content of this report. Where precise information was not available, a consensus was made using a formulation of reasonable assumptions and estimates based on historical data.

RELATED WORK CREDENTIALS

The author of this report, Norma Corbitt, has over 14 years of experience with BCC as an editor and project analyst. Corbitt contributes to several BCC newsletters, including Flame Retardancy News, Food Ingredients News, High-Tech Separations News, and Battery and EV Technology. Recent technical/marketing reports include Advanced Inorganic Fillers for Plastics, Inorganic Membranes, Flame Retardant Chemicals, and Bioseparations.

RELATED REPORTS

• RELATED BCC REPORTS
• B-106 Drug Discovery Technologies: A Combination of Technologies
• B-125 Medical Needs for the Elderly Living at Home
• B-127 Microelectronic Medical Devices
• PHM021A Pharmaceuticals for Neurodisorders and Imbalances
• C-047U Cancer Treatment and Diagnostic Products
• C-058N The Worldwide Generic Prescription Drug Industry
• HLC008D The Blood Industry
• GB-157 The Dental Market: Techniques, Equipment, and Materials

REPORT TOC